Gefitinib usage and outcomes in routine treatment

Study identifier:NIS-OGB-IRE-2012/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A multicentre, retrospective chart review study to characterise gefitinib usage and outcomes in routine treatment

Medical condition

lung cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

157

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jun 2013
Primary Completion Date: 01 Nov 2013
Study Completion Date: 01 Nov 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Oct 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria